Lipitoratorvastatin

242,937 adverse event reports submitted to the FDA (2000–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Lipitor in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Lipitor adverse event reports by reporter sex
SexReports
Female122,506
Male103,698
Unknown2,297

By Age Group

View age group data as a table
Lipitor adverse event reports by reporter age group
Age groupReports
0-17581
18-341,645
35-4912,687
50-6450,391
65-7445,145
75+39,014

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Lipitor. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Lipitor adverse event reports by reported outcome
OutcomeReports
Other Serious105,425
Non-Serious84,640
Hospitalization69,302
Death18,535
Disability7,697
Life-Threatening7,308

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Lipitor. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Lipitor adverse event reports by year
YearReports
20001
20035
20045,709
20057,587
20068,145
20076,977
20086,528
20097,351
201014,616
201111,548
201213,810
201310,592
201415,345
201515,342
201614,717
201712,744
201812,857
201913,141
202012,174
202110,528
202210,497
20239,451
20249,960
202510,897
2026 (partial)2,415

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Lipitor

In FDA adverse event reports that mention Lipitor, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026